PS
Therapeutic Areas
Rapport Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RAP-219 | Treatment-Resistant Epilepsy / Focal Onset Seizures | Phase 1 |
| nAChR α6 Program | Chronic Pain | Discovery |
| nAChR α9α10 Program | Hearing Disorders | Discovery |
| Drug | Indication | Phase |
|---|---|---|
| RAP-219 | Treatment-Resistant Epilepsy / Focal Onset Seizures | Phase 1 |
| nAChR α6 Program | Chronic Pain | Discovery |
| nAChR α9α10 Program | Hearing Disorders | Discovery |